A controversial topic that is currently being considered is the application of an early HPV vaccination in younger girls and boys. This sensitive subject has ethical implications and valid points can be argued both for and against the concept. Individuals that are for early vaccination hold that the vaccine prevents transmission of HPV, decreases chances of developing future complications, and is more cost effective in the long run. Individuals that take a stand against early vaccination will say the vaccine promotes risky sexual behavior, is not safe, takes away from parent’s autonomy, and is not cost effective in the immediate period. The following information will give insight to both sides of the argument and a personal stance on the issue. The first example in support of early vaccination is the prevention of transmission of human papilloma virus (HPV). There are symptoms that can occur as a result of having an HPV infection. Gardasil is found to be successful in preventing HPV infections from types 6, 11, 16, and 18 (Donahou, 2013). A benefit of the HPV vaccine is the provision that there is use of accepted medical technology that will prevent serious diseases when possible and minimize pain and suffering (Donahou, 2013). Vaccinating both young girls and boys is found to reduce HPV transmission (Chen, Shepherd, & Becker, 2012). White states “this vaccination may help prevent the spread of genital warts in both sexes in addition to the cancer prevention rationale.” Also in the article, “There are also documented benefits to male patients regarding a decrease in sexually-transmitted lesions from female sexual partners who have been vaccinated” (White, 2014).
According to Navarro-Illana, et al. (2014), studies have been conducted to show the vaccination is most
